Mortality Analysis in Patients With Atrial Fibrillation and Implantable Permanent Pacemaker After Ablation of the Atrioventricular Node

Journal of Insurance Medicine: Vol. 34, No. 2, pp. 92–93.
Abdelouahed Naslafkih, MD, MSc,a
and Francois Sestier, MD, PhD, FACC

C.P. 6128 Succ. Centre-ville, Montreal (QC) Canada
H3C 3J7; E-mail: francois.sestier@umontreal.ca
Mortality Article 304N-6

http://www.mae.umontreal.ca/documents/mortality.pdf

ABSTRACT
Objective.—Atrial fibrillation is associated with excess mortality. This analysis was performed to determine the magnitude of the excess mortality risk.
Methods.—Life table analysis of a published study of 350 patients undergoing radiofrequency ablation of the atrioventricular node and permanent pacemaker implantation for symptomatic paroxysmal or chronic atrial fibrillation. A substantial proportion of subjects had evidence of left ventricular dysfunction.

Results.—In this cohort, compared to expected population mortality, the relative mortality
ratio was 234% and the annual excess death rate was 46 deaths/1000.